DECIPHERA PHARMACEUTICALS IN's ticker is DCPH and the CUSIP is 24344T101. A total of 146 filers reported holding DECIPHERA PHARMACEUTICALS IN in Q1 2023. The put-call ratio across all filers is 0.80 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,155 | -9.7% | 248 | 0.0% | 0.00% | – |
| Q2 2023 | $3,492 | -8.9% | 248 | 0.0% | 0.00% | – |
| Q1 2023 | $3,832 | -5.7% | 248 | 0.0% | 0.00% | – |
| Q4 2022 | $4,065 | -18.7% | 248 | -2.7% | 0.00% | – |
| Q3 2022 | $5,000 | +66.7% | 255 | +2.8% | 0.00% | – |
| Q2 2022 | $3,000 | – | 248 | +651.5% | 0.00% | – |
| Q1 2022 | $0 | -100.0% | 33 | -95.1% | 0.00% | – |
| Q4 2021 | $7,000 | +133.3% | 674 | +674.7% | 0.00% | – |
| Q3 2021 | $3,000 | – | 87 | +770.0% | 0.00% | – |
| Q2 2021 | $0 | -100.0% | 10 | -71.4% | 0.00% | – |
| Q1 2021 | $2,000 | +100.0% | 35 | +250.0% | 0.00% | – |
| Q4 2020 | $1,000 | -50.0% | 10 | -75.0% | 0.00% | – |
| Q3 2020 | $2,000 | -50.0% | 40 | -41.2% | 0.00% | – |
| Q2 2020 | $4,000 | – | 68 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Leaf Venture Partners, L.L.C. | 1,209,571 | $15,385,743 | 19.76% |
| Redmile Group, LLC | 4,475,384 | $56,926,884 | 2.71% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 6,897,606 | $87,737,548 | 1.93% |
| Parkman Healthcare Partners LLC | 597,403 | $7,598,966 | 1.39% |
| Ghost Tree Capital, LLC | 325,000 | $4,134,000 | 1.36% |
| BRAIDWELL LP | 3,336,221 | $42,436,731 | 1.34% |
| AlphaCentric Advisors LLC | 132,000 | $1,679,040 | 0.95% |
| ARMISTICE CAPITAL, LLC | 4,612,000 | $58,664,640 | 0.90% |
| Sunesis Advisors, LLC | 96,299 | $1,224,923 | 0.87% |
| EcoR1 Capital, LLC | 993,000 | $12,630,960 | 0.43% |